Clinical Trials & Research
Search Clinical Trials
Our Blood and Marrow Transplant Program is recognized as a leader in the field of blood and marrow transplant and patients are referred to us because of both our clinical excellence and advanced treatment protocols. Our objective is to have research trials available for most clinical situations to meet the needs of our patients. Our record shows that we are committed to reduce transplant toxicities and improve patient outcomes.
Search our database for a listing of clinical trials available at Taussig Cancer Institute.
Search Clinical Trials
The Blood & Marrow Transplant Clinical Trials Network
The Blood and Marrow Transplant Program collaborates with the BMT Clinical Trials Network (BMT CTN). BMT CTN was established because of a critical need for multi-institutional clinical trials focused directly on improving survival for patients undergoing hematopoietic cell transplantation (HCT).
Since 2001, the BMT CTN has opened more than 27 multi-institutional phase II and III trials, involved more than 100 transplant centers, and enrolled thousands of patients.
The Center for International Blood & Marrow Transplant Research
The Center for International Blood & Marrow Transplant Research (CIBMTR) collaborates with the global scientific community to advance hematopoietic cell transplantation (HCT) and cellular therapy research worldwide.
A research program of the National Marrow Donor Program®/Be the Match and the Medical College of Wisconsin; CIBMTR facilitates critical research that has led to increased survival and an enriched quality of life for thousands of patients.
The Chronic Graft-versus-host Disease Consortium
The Chronic GVHD Consortium is an integrated group of academic medical centers, patient support organizations, and clinical research resources dedicated to conducting clinical research in different immune mediated disorders after allogeneic hematopoietic cell transplantation and improving the care of patients affected by these disorders. Funded by the National Institutes of Health (NIH), the Chronic GVHD Consortium is part of the Rare Diseases Clinical Research Network.
The Chronic Graft-versus-host Disease Consortium seeks to decrease illness, limit disability and prevent death for patients who develop immune-mediated complications after allogeneic hematopoietic cell transplantation.
Cancer Answers & Appointments
Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.
Monday through Friday from 8 a.m. – 4:30 p.m. (ET).
Resources for medical professionals
- Outpatient appointment referrals: 216.444.7923 or 866.223.8100
- Inpatient hospital transfers: 800.553.5056
- Referring Physician Concierge: 216.444.6196 or 216.312.4910.
Search available cancer clinical trials by disease, hospital, phase or number.
This information is provided by Cleveland Clinic and is not intended to replace
the medical advice of your doctor or health care provider.
Please consult your health care provider for advice about a specific medical condition.
© Copyright 2015 Cleveland Clinic. All rights reserved.